Eagle Boston Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $1.16M | Sell |
|
|||||
|
2019
Q1 | $4.08M | Sell |
|
|||||
|
2018
Q4 | $4.29M | Sell |
|
|||||
|
2018
Q3 | $14.5M | Buy |
|
|||||
|
2018
Q2 | $11.8M | Buy |
|
|||||
|
2018
Q1 | $10.3M | Buy |
|
|||||
|
2017
Q4 | $9.99M | Buy |
|
|||||
|
2017
Q3 | $9.41M | Buy |
|
|||||
|
2017
Q2 | $8.55M | Sell |
|
|||||
|
2017
Q1 | $7.62M | Buy |
|
|||||
|
2016
Q4 | $6.13M | Buy |
|
|||||
|
2016
Q3 | $6.7M | Buy |
|
|||||
|
2016
Q2 | $6.57M | Buy |
|
|||||
|
2016
Q1 | $5.9M | Buy |
|
|||||
|
2015
Q4 | $6.05M | Sell |
|
|||||
|
2015
Q3 | $5M | Buy |
|
|||||
|
2015
Q2 | $5.32M | Sell |
|
|||||
|
2015
Q1 | $8.38M | Sell |
|
|||||
|
2014
Q4 | $9.58M | Sell |
|
|||||
|
2014
Q3 | $11.8M | Sell |
|
|||||
|
2014
Q2 | $11M | Sell |
|
|||||
|
2014
Q1 | $12.7M | Sell |
|
|||||
|
2013
Q4 | $11.8M | Buy |
|
|||||
|
2013
Q3 | $7.28M | Sell |
|
|||||
|
2013
Q2 | $6.58M | Buy |
|